These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15605700)

  • 1. Effective anticoagulation therapy: defining the gap between clinical studies and clinical practice.
    Wittkowsky AK
    Am J Manag Care; 2004 Oct; 10(10 Suppl):S297-306; discussion S312-7. PubMed ID: 15605700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economics of anticoagulation: what are the issues?
    Am J Manag Care; 2004 Oct; 10(10 Suppl):S292-6. PubMed ID: 15605699
    [No Abstract]   [Full Text] [Related]  

  • 3. The need for new oral anticoagulants in clinical practice.
    Hylek EM
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention.
    Peterson GM; Boom K; Jackson SL; Vial JH
    Intern Med J; 2002; 32(1-2):15-23. PubMed ID: 11783668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation in atrial fibrillation. Is there a gap in care for ambulatory patients?
    Putnam W; Nicol K; Anderson D; Brownell B; Chiasson M; Burge FI; Flowerdew G; Cox J
    Can Fam Physician; 2004 Sep; 50():1244-50. PubMed ID: 15508374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study).
    Friberg L; Hammar N; Ringh M; Pettersson H; Rosenqvist M
    Eur Heart J; 2006 Aug; 27(16):1954-64. PubMed ID: 16847008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for stroke and thromboprophylaxis in atrial fibrillation: what happens in daily clinical practice? The GEFAUR-1 study.
    Laguna P; Martn A; del Arco C; Gargantilla P;
    Ann Emerg Med; 2004 Jul; 44(1):3-11. PubMed ID: 15226703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation.
    Leey JA; McCabe S; Koch JA; Miles TP
    Am J Geriatr Pharmacother; 2009 Aug; 7(4):197-203. PubMed ID: 19766951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke prevention in atrial fibrillation: are we following the guidelines?
    Pusser BE; Robertson SL; Robinson MD; Barton C; Dobson LA
    N C Med J; 2005; 66(1):9-13. PubMed ID: 15786672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of anticoagulation for stroke prevention and risk stratification in atrial fibrillation: translating trials into clinical practice.
    Go AS
    Am J Manag Care; 2004 Apr; 10(3 Suppl):S58-65. PubMed ID: 15152747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy.
    Partington SL; Abid S; Teo K; Oczkowski W; O'Donnell MJ
    Thromb Res; 2007; 120(5):663-9. PubMed ID: 17434577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current approaches to anticoagulation for reducing risk of atrial fibrillation-related stroke.
    Sanoski CA
    J Pharm Pract; 2013 Jun; 26(3):204-13. PubMed ID: 22842506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newly detected atrial fibrillation and compliance with antithrombotic guidelines.
    Glazer NL; Dublin S; Smith NL; French B; Jackson LA; Hrachovec JB; Siscovick DS; Psaty BM; Heckbert SR
    Arch Intern Med; 2007 Feb; 167(3):246-52. PubMed ID: 17296879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of care for atrial fibrillation among patients hospitalized for heart failure.
    Piccini JP; Hernandez AF; Zhao X; Patel MR; Lewis WR; Peterson ED; Fonarow GC;
    J Am Coll Cardiol; 2009 Sep; 54(14):1280-9. PubMed ID: 19778670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
    Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
    J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing the guard in long-term anticoagulation: clinical and economic implications.
    Lepor NE
    Rev Cardiovasc Med; 2004; 5 Suppl 5():S22-9. PubMed ID: 15619612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.